Work

246 Overall Survival With Sunitinib Versus Interferon-alfa (ifn-□) as First-line Treatment for Metastatic Renal Cell Carcinoma (mrcc)

Year: 2009

Type: conference-abstract

Source: European Urology Supplements

DOI: 10.1016/s1569-9056(09)60251-7

Authors: C. Szczylik, S. Negrier, S. Oudard, R.A. Figlin, T.E. Hutson, P. Tomczak, M.D. Michaelson, R.M. Bukowski, X. Huang, S.T. Kim, I. Chen, R.J. Motzer

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2021759282

Cites:

Cited by: 11

Related to: 10